Investor desk
Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from RESI San Diego.
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of on
Presentation data updated Jun 5, 2026, 11:28 AM UTC
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.
Expect signals on pricing, formulary strategy, and partnership economics relevant to biotech markets in the US region.
FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at biotech leadership forums.
Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from RESI San Diego.
Competitive positioning among top biotech players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Tier-1 industry catalyst
RESI San Diego is a targeted biotech forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
Moderate coverage; Nova editorial will prioritize confirmed data releases.
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
Early science or services-focused — lower near-term PDUFA linkage.
Some historical catalysts; compare readouts against last cycle.
Meaningful sponsor footprint; BD teams can pre-book partnering slots.
Nova Pharma Intelligence · Analyst desk
6 presentations tracked — Key Data and Companies hubs live.
Live readouts, late-breakers, and partnership announcements.
1 Nova articles linked — see Coverage & Analysis.
Post-event recap, competitive takeaways, and trial updates.
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.
Primary audience: Investors & analysts
Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from RESI San Diego.
FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at biotech leadership forums.
Competitive positioning among top biotech players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
| Edition | Presentations | Companies |
|---|---|---|
| RESI San Diego (current) | 6 | 5 |
| RESI Boston 2026 (2026) | 0 | 0 |
Top-line Data Readout of the Twin Phase 3 ENSURE Trials
1-Year Data from the REVEAL-1 Cohort of Revita
1-Year Randomized Data from the REMAIN-1 Midpoint Cohort of Revita
New Rese-cel Data in Dermatomyositis: 83% of Patients Would Have Met Registrational Primary Endpoint
Randomized EXALT-2 Trial: Clinical Utility and Health Outcomes
Competitive positioning among top biotech players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
No coverage articles yet. Check back closer to the event.
Standalone summaries for RESI San Diego — optimized for research and AI retrieval.
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.
Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from RESI San Diego.
BD teams should prioritize networking with presenting companies and services vendors at RESI San Diego, focusing on biotech partnership and licensing opportunities.
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
RESI San Diego is a biotech industry conference bringing together executives, clinical leaders, and investors to discuss pipeline, regulatory, and commercial strategy.
Typical attendees include pharma executives, BD teams, investors, regulatory affairs professionals, and clinical operations leaders focused on biotech.
RESI San Diego influences partnership timing, pipeline prioritization, and policy debates that affect biotech markets for the next 12–18 months.
RESI San Diego takes place on the scheduled dates.
RESI San Diego is held in the listed venue.
RESI San Diego typically draws 300+ attendees from across the biotech ecosystem.
5+ companies present data or participate in programming at RESI San Diego, spanning large pharma, biotech, and services vendors.
Investors should track partnership announcements, pipeline readouts, M&A signals, and management commentary on biotech catalysts during and after RESI San Diego.
BD teams use RESI San Diego for licensing discussions, co-development talks, and vendor selection across biotech — especially in networking sessions and satellite meetings.
RESI San Diego is a tier-1 global congress for biotech — compare speaker quality, company participation, and historical deal flow with peer events in the same therapeutic or commercial vertical.
NovaPharmaNews publishes pre-event briefs, live coverage, and post-event analysis for RESI San Diego. Subscribe to event alerts on this page for breaking updates.